TP53 and leukemia: In addition, an experimental study showed that restoring miR-34c-5p expression could prevent leukemia development and promote LSC senescence via interaction with the p53-p21Cip1-Cyclin-dependent kinase (CDK)/Cyclin or p53-independent CDK/Cyclin pathways.